1. Home
  2. GERN vs HNRG Comparison

GERN vs HNRG Comparison

Compare GERN & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • HNRG
  • Stock Information
  • Founded
  • GERN 1990
  • HNRG 1949
  • Country
  • GERN United States
  • HNRG United States
  • Employees
  • GERN N/A
  • HNRG N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • HNRG Coal Mining
  • Sector
  • GERN Health Care
  • HNRG Energy
  • Exchange
  • GERN Nasdaq
  • HNRG Nasdaq
  • Market Cap
  • GERN 740.5M
  • HNRG 823.6M
  • IPO Year
  • GERN 1996
  • HNRG N/A
  • Fundamental
  • Price
  • GERN $1.12
  • HNRG $20.20
  • Analyst Decision
  • GERN Buy
  • HNRG Strong Buy
  • Analyst Count
  • GERN 7
  • HNRG 4
  • Target Price
  • GERN $3.00
  • HNRG $20.00
  • AVG Volume (30 Days)
  • GERN 8.6M
  • HNRG 545.1K
  • Earning Date
  • GERN 11-05-2025
  • HNRG 11-10-2025
  • Dividend Yield
  • GERN N/A
  • HNRG N/A
  • EPS Growth
  • GERN N/A
  • HNRG N/A
  • EPS
  • GERN N/A
  • HNRG N/A
  • Revenue
  • GERN $183,403,000.00
  • HNRG $461,142,000.00
  • Revenue This Year
  • GERN $166.20
  • HNRG $11.19
  • Revenue Next Year
  • GERN $55.83
  • HNRG $4.79
  • P/E Ratio
  • GERN N/A
  • HNRG N/A
  • Revenue Growth
  • GERN 522.13
  • HNRG 7.15
  • 52 Week Low
  • GERN $1.04
  • HNRG $8.37
  • 52 Week High
  • GERN $4.21
  • HNRG $24.70
  • Technical
  • Relative Strength Index (RSI)
  • GERN 40.96
  • HNRG 48.51
  • Support Level
  • GERN $1.04
  • HNRG $19.33
  • Resistance Level
  • GERN $1.28
  • HNRG $24.70
  • Average True Range (ATR)
  • GERN 0.07
  • HNRG 1.39
  • MACD
  • GERN 0.00
  • HNRG -0.04
  • Stochastic Oscillator
  • GERN 30.12
  • HNRG 16.88

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About HNRG Hallador Energy Company

Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.

Share on Social Networks: